Clinical Trial 49138

Marlton, NJ 08053


A Phase 1, Randomized, Double Blind, Placebo Controlled, Serial Cohort Dose Escalation Study to assess the safety, tolerability, and pharmacokinetics of single oral doses of AT-1082 in Healthy Nonsmoking Adults.

Qualified Participants Must:

• Be 18-55 years old
• Have BMI between 18-32
• Be a poor metabolizer of CYP2D6 Enzyme
• Be a nonsmoker

Qualified Participants May Receive:

Compensation for time and travel.

Transportation provided and No insurance needed.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.